Fertility and Sterility
Volume 89, Issue 3 , Pages 502-504, March 2008

Tobacco and fertility: our responsibilities

  • Sally Faith Dorfman, M.D., M.S.H.S.A.

      Affiliations

    • Corresponding Author InformationReprint requests: Sally Faith Dorfman, M.D., Ferring Pharmaceuticals, Inc., 4 Gatehall Drive, Third Floor, Parsippany, NJ 07054 (FAX: 973-796-1663).

Ferring Pharmaceuticals, Inc., Parsippany, New Jersey

Received 30 October 2007; received in revised form 21 December 2007; accepted 3 January 2008.

Publication of the new US Public Health Service-sponsored Clinical Practice Guideline, Treating Tobacco Use and Dependence: 2008, coupled with the persistent prevalence of tobacco use in the reproductive-age population and the negative effect of tobacco on fertility, prompts an updated review of this topic, geared to those who treat infertility.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of interest: Dr. Dorfman is an employee of Ferring Pharmaceuticals, Inc. (FPI), a company whose business does not relate to treating tobacco dependence; FPI has no medication that assists smoking cessation. Dr. Dorfman is a member of the Guideline Panel for the USPHS-sponsored Clinical Practice Guideline, Treating Tobacco Use and Dependence: 2008.

PII: S0015-0282(08)00017-4

doi:10.1016/j.fertnstert.2008.01.011

Fertility and Sterility
Volume 89, Issue 3 , Pages 502-504, March 2008

Article Tools